New UK Rare Disease Framework Seeks To Reduce ‘Diagnostic Odyssey’ For Patients
Executive Summary
England, Scotland, Wales and Northern Ireland will publish their respective action plans to deliver the aims of the UK’s new framework for rare diseases.
You may also be interested in...
New UK Rare Disease Framework Seeks Better Patient Access & More International Collaboration
England, Scotland, Wales and Northern Ireland will publish their respective action plans to deliver the aims of the UK’s new framework for rare diseases.
UK Conservatives Promise ‘Innovative Medicines Fund’ If Re-Elected
More money to pay for innovative new medicines, more cash and support for the life sciences sector, and Brexit by 31 January 2020 are among promises made in the Conservative Party’s election platform.
EU Crunch Time For Two Drugs That Lost Their Fast-Track Status
Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: